“At any given time, more than 100,000 American families — most of whom are African American — are affected by sickle cell disease, an inherited and often stigmatized condition that often causes painful episodes and can even lead to a shortened lifespan.” Aflac Senior Vice President, Federal Relations Bradley Knox said. “Aflac’s contribution will help Children’s National Hospital conduct groundbreaking research that we hope will one day lead to a universal cure for this terrible disease that affects 1 in 365 African Americans. We are delighted to provide a day at the stadium to celebrate the children, families and carers who are coping with the effects of sickle cell disease every day.”
“We are honored for Aflac’s partnership to ensure Children’s National can provide expert care and groundbreaking research to support children and their families battling sickle cell disease across the greater metropolitan area Washington, D.C metropolitan area,” said Julia Butler, Vice President of the National Hospital Foundation for Children. “Your generous donation to our research program will help us to develop and implement treatments that are both innovative and family-focused. We are grateful for Aflac’s financial support and for creating wonderful memories for our families like the Nationals game on World Sickle Cell Day! “
Children who participated in the ball game also received their own My Special Aflac Duck®a robotic duck that has helped nearly 16,000 children cope with their cancer or sickle cell diagnosis and treatment. My special Aflac ducks are provided to children free of charge. Children and caregivers use the medical play ducks to help children better understand their treatments and communicate their feelings, which is sometimes difficult for children.
That My special Aflac duck Program was launched in 2018 for children with cancer. After 18 months of research involving patients, families and caregivers, Aflac expanded the program by developing accessories specifically designed to address the challenges associated with sickle cell disease.
“Families confronted with sickle cell disease often feel forgotten because funding and awareness of the disease is far less than for similar inherited disorders,” Knox said. “Extension of our My special Aflac duck Program and providing funding for research and treatment improvements at a renowned hospital like Children’s National is our way of saying, ‘You have not been forgotten and we are here with you.'”
Since 1995, Aflac has donated more than 160 million dollars to the Aflac Cancer and Blood Disorders Center of Children’s Healthcare Atlantawhich is also home to the most productive sickle cell treatment facility in America.
ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL) is a Fortune 500 company, which through its subsidiaries in Japan and the US, which pays cash quickly when policyholders get sick or injured. For more than six decades, Aflac Incorporated’s subsidiary insurance policies have offered policyholders the opportunity to focus on recovery rather than financial burdens. Aflac is the leading provider of supplementary health insurance in the USA1. Aflac Life Insurance Japan is the leading health and cancer insurance provider in Japan Japan, where 1 in 4 households are insured. In 2021, Aflac Incorporated was proud to be recognized by Ethisphere as one of the World’s Most Ethical Companies for the 16th consecutive year. Also in 2021, the company was included in the Dow Jones Sustainability North America Index and became a signatory to the Principles for Responsible Investment (PRI). In 2022, Aflac Incorporated was named to Fortune’s list of the World’s Most Admired Companies for the 21st time and the Bloomberg Gender-Equality Index for the third consecutive year. To find out how to get help for expenses not covered by health insurance, meet us at aflac.com or aflac.com/español. Investors can learn more about Aflac Incorporated and its commitment to ESG and social responsibility at investors.aflac.com under “Sustainability.”
1 LIMRA 2021 U.S. Comprehensive Supplemental Health Insurance Market Report
Media contact: Jon Sullivan706-763-4813 or [email protected]
Analyst and investor contact: David A Jung706-596-3264, 800-235-2667 or [email protected]